The Center for Genetic Engineering and Biotechnology (CIGB) calls on national and foreign scientists to participate in the International Congress on Biopharm Nonclinical Development, BionCiD 2025 (Congress on nonclinical biopharmaceutical development) to be held in Varadero from May 25 to 29.
According to information released by the institution on its website, the purpose of the event will be to bring together experts, academics and professionals from the sector to discuss the latest advances in research for the nonclinical development of innovative biopharmaceuticals, promoting compliance with the 3Rs and the culture of care.
The topics to be discussed include non-clinical development programs for drugs and biopharmaceutical products, advances in pharmacokinetics and toxicology, trends in the evaluation of drug-drug interactions, biopharmaceutical products and microbiota, as well as the update of the non-clinical regulatory framework, which will be part of the academic program.
Also included are staff training and accreditation of facilities, the Institutional Animal Care and Use Committee (IACUC) and its role in non-clinical development, animal and human welfare: behavior management and implementation of a culture of care according to non-clinical regulatory requirements and application of the 3Rs and domestic cage monitoring technologies and improvement of non-clinical to clinical translation.
Animal models will also be discussed: development and use, challenges and perspectives, in silicon, mathematical and other alternative methods of non-clinical development and sponsorship packages.
The CIGB was founded on July 1, 1986, and has become a large research-production complex equipped with cutting-edge equipment, significant production capacities and a staff engaged in the development of new products in all its phases, from the conception and expression of proteins with DNA recombination techniques to industrial-scale production and marketing of its products.
For more information, please visit the website: /event/international-congress-biopharm-nonclinical-development-bioncid-2025
CubaPLUS Latinos
CubaPLUS Guyana
CubaPLUS Travel